Seneste videoer
Multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell. Healthy plasma cells help fight infections by making antibodies that recognize and attack germs. In multiple myeloma, cancerous plasma cells accumulate in the bone marrow and crowd out healthy blood cells. Learn more about potential symptoms of the condition, along with how the disease is diagnosed and treated.
Anna Jones, M.D. is a physician in Hematology and Oncology at Mayo Clinic Health System in La Crosse, Wisconsin offering a full range of cancer information, resources and options, including:
• Chemotherapy
• Emotional and spiritual guidance
• Hospice
• Nutrition counseling
• Pain management
• Palliative care
• Radiation therapy
• Screenings
• Specialized oncology nursing
• Surgery
For more Hematology and Oncology Information, please go to: https://mayocl.in/3Kr4768
From Mayo Clinic to your inbox, sign-up for free: https://mayocl.in/3e71zfi
Schedule your appointment at Mayo Clinic Health System: https://mayocl.in/3lO95iY
SUBSCRIBE & HIT THE 🔔 http://bit.ly/2VW2yV1
#cancercare #multiplemyeloma #mayoclinichealthcare #mayoclinicexperience #mayoclinichealthsystem #mayoclinic
Follow Mayo Clinic Health System on
Facebook:
http://bit.ly/2VXSYRv
On Instagram at:
http://bit.ly/30obB03
And also on Twitter:
http://bit.ly/2JgsHI5
Presented By:
Ola Landgren, M.D., Ph.D. - Professor of Medicine & Chief of Multiple Service at Memorial Sloan-Kettering in New York City
Speaker Biography:
Dr. Landgren is Professor of Medicine and Chief Attending Physician of the Myeloma Service at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York, NY. Dr. Landgren is one of the world leaders in the field of early treatment strategies and molecular- and cell-based monitoring of minimal residual disease (MRD) detection in multiple myeloma and its precursor states. He leads a translational research program at MSKCC designed to discover new treatment paradigms integrating modern therapy and novel MRD assays. Dr. Landgren has designed and led the definitive study showing that all multiple myeloma patients are preceded by a precursor stage. As part of his ongoing research program, he is studying molecular mechanisms underlying the trajectory from precursor to full-blown multiple myeloma with the goal to develop of treatment strategies aiming to delay, prevent, and ultimately define a cure for multiple myeloma.
Dr. Landgren has published over 250 peer-reviewed publications and he is a frequently invited speaker at national and international hematology conferences. He serves on several research committees and editorial boards for scientific journals.
Webinar:
Common symptoms and presentations of Multiple Myeloma to primary care physicians
Abstract:
Board-certified hematologist-oncologist Ola Landgren, MD, PhD, will review how vague symptoms (fatigue, bone pain, back pain) are linked to the possibility of underlying Multiple Myeloma and what guideline-recommended tests should be used for diagnosis. Primary care physicians see 50% of Myeloma patients with early symptoms, and early identification and diagnosis are key to starting earlier treatment for Multiple Myeloma patients and preventing secondary complications.
Sponsored By:
The Binding Site
Earn PACE Credits:
1. Make sure you’re a registered member of LabRoots - https://www.labroots.com/ms/we....binar/common-symptom
2. Watch the webinar on YouTube or on the LabRoots Website - https://www.labroots.com/ms/we....binar/common-symptom
3. Click Here to get your PACE credits (Expiration date – September 21, 2019 08:00 AM) - http://www.labroots.com/credit..../pace-credits/2441/t
LabRoots on Social:
Facebook: https://www.facebook.com/LabRootsInc
Twitter: https://twitter.com/LabRoots
LinkedIn: https://www.linkedin.com/company/labroots
Instagram: https://www.instagram.com/labrootsinc
Pinterest: https://www.pinterest.com/labroots/
SnapChat: labroots_inc
in this short tutorial,i e part 1 of plasma cell disorders , i have discussed the structure and function of plasma cells, overview of plasma cell disorders and the etiopathogenesis and clinical features of multiple myeloma
to know more about this topic click here https://ilovepathology.com/pat....hology-of-multiple-m
Click on website http://ilovepathology.com/ for more content for undergraduate students in pathology.
Please feel free to post queries or comment on the video😊 Good luck.
Learn about what multiple myeloma is, how it develops, and what kind of treatments are available. Please talk with your doctor and see the NCCN Guidelines for Patients: Multiple Myeloma for more information. https://www.nccn.org/patientre....sources/patient-reso
You and your doctor are a team in your care. This video is for informational purposes only and is not intended to be a substitute for medical advice. Talk with your doctor to determine the right course of treatment for you.
Supporters:
This video is presented with support from the NCCN Foundation and by contributions from our corporate supporters, GlaxoSmithKline, Oncopeptides, and Sanofi Genzyme.
NCCN Guidelines for Patients are developed independently and corporate supporters do not participate in their development.
________________________________________________________________
About NCCN Foundation®:
NCCN FOUNDATION® is a 501(c)3 organization founded by the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education—to empower people living with cancer and advance oncology innovation. For more information or to make a donation, visit www.nccn.org/patients/foundation
________________________________________________________________
About NCCN:
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Visit https://www.nccn.org/ for more information.
Subscribe to our channel for the latest in cancer care: https://www.youtube.com/c/NCCNvideo?s...
Connect with us!
Twitter: https://twitter.com/NCCN
LinkedIn: https://www.linkedin.com/company/nccn/
Facebook: https://www.facebook.com/NCCNorg
Instagram: https://www.instagram.com/NCCNorg/
In the following video, Rafael Fonseca, M.D., Director of the Cancer Center at Mayo Clinic in Arizona, provides an overview of the condition Multiple Myeloma (a cancer that arises from the blood marrow) and describes treatment options. To learn more about Multiple Myeloma, visit: https://mayocl.in/2N4dM48
To request an appointment at Mayo Clinic, visit: https://mayocl.in/37LsLrv
Multiple myeloma is a cancer of plasma cells, which are a typically located in the bone marrow. The bone marrow is the soft, sponge-like tissue in the center of most bones. Dr. Cesar Rodriguez Valdes discusses what you need to know about multiple myeloma, including how it is diagnosed, treatment options, the stages, and if it is hereditary.
Each episode of #MountSinaiLive delivers easy-to-understand information to improve your health. You can see more episodes here: https://mshs.co/2Fg
Book an appointment with Dr. Cesar Rodriguez: https://www.mountsinai.org/pro....files/cesar-rodrigue
Visit the Center of Excellence for Multiple Myeloma at Mount Sinai: https://www.mountsinai.org/car....e/cancer/services/mu
What happens in early stages of multiple myeloma? Watch as early multiple myeloma is explained as expert Dr. Rafael Fonseca details what occurs in the body, and patient Lisa Hatfield shares the symptoms that she experienced early in her myeloma journey.
Patient Empowerment Network (PEN) is a 501(c)(3) non-profit organization. PEN’s mission is to fortify cancer patients and care partners with the knowledge and tools to boost their confidence, put them in control of their healthcare journey, and assist them in receiving the best, most personalized care available to ensure they have the best possible outcome. Subscribe now to receive the latest news on cancer treatment and research: https://powerfulpatients.org/connect
